Using data from the NHANES survey, Stanford researchers found that….

Study shows data that negates resveratrol’s use in metabolic disorders as a nutritional supplement….

This week we continue our Clinical Text focus on macrovascular disease associated with diabetes. Dr. Beaser gets into a discussion as to which patients should be on aspirin therapy and how the use of a particular ACE-inhibitor can make a significant difference in MI risk reduction. The Homerun Slides continue …

An abundance of excitement has surrounded the FDA approval of the sodium glucose cotransporter 2 inhibitor (SGLT2 –I), Invokana. So why did we need to introduce a 14th class of medication for treating diabetes? That answer was simple for Richard Aguilar, MD, Medical Director, Diabetes Nation, and Diabetes Care Foundation, …

In this set of Homerun Slides, we give you a brief overview of the functioning of this new class of drugs, and get into the specifics of the first drug in its class approved by the FDA, canagliflozin (Invokana)…. Link to download (.ppt format): SGLT-2 Inhibitors: A New Modality for Treating …

  This week’s set of Homerun Slides topics include: The Role of Incretins in Type 2 Diabetes; Non-insulin injection for DM2; and a discussion of the ADOPT study….

Richard S. Beaser, MD Michael Johnstone, MD   This week’s excerpt answers the following questions:  What are the three disorders of coagulation and fibrinolysis that increase the risk of developing macrovascular disease When and who should be on aspirin therapy How to reduce macrovascular risks Which ACE inhibitor reduces the …

This past week I was in the DC area talking to physicians about patient-centered Medical Homes and Accountable Care Organizations (ACO’s). Much of the conversation revolved around Medicare and Medicaid plans and patients. As we were talking about opportunities for the future the conversation turned toward working directly with companies …

SENSUS™ Pain Management  The SENSUS Pain Management System is a transcutaneous electrical nerve stimulator uniquely designed for people with diabetes and chronic pain. It is a device that is worn on one or both legs and is activated by simply pressing a button. SENSUS provides pain relief by comfortably stimulating the …

FreeStyle® InsuLinx Glucose Meter Recall  Abbott has issued a recall for the FreeStyle InsuLinx Blood Glucose Meters in the United States to address the potential for an inaccurate reading at rare, extremely high blood glucose levels. The reason for the recall is similar to what made LifeScan recall their new …